Evidence map›Paper›PMID 39770778›Full record

ArticleMicroorganisms2024

Understanding the Epidemiology of Monkeypox Virus to Prevent Future Outbreaks.

Jimmy Steven Velásquez, Fabiola Beatriz Herrera-Echeverría, Héctor Salvador Porres-Paredes, Carmen Rodríguez-Cerdeira

Abstract read
In one paragraph

Article in Microorganisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jimmy Steven VelásquezDermatology Department, Hospital Regional de Occidente San Juan de Dios, Quetzaltenango 09001, Guatemala.ORCID 0000-0001-7937-4459
Fabiola Beatriz Herrera-EcheverríaDermatology Department, Hospital General San Juan de Dios, Guatemala 01001, Guatemala.
Héctor Salvador Porres-ParedesDermatology Department, Hospital Regional de Occidente San Juan de Dios, Quetzaltenango 09001, Guatemala.
Carmen Rodríguez-CerdeiraFundación Vithas, Grupo Hospitalario Vithas, 28043 Madrid, Spain.ORCID 0000-0001-9939-0771

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Monkeypox (Mpox) is an infectious disease caused by the Mpox virus belonging to the Orthopoxvirus genus in the Poxviridae family and has been declared by the WHO as a global health emergency owing to its rapid spread during 2022 and 2023. All patients diagnosed with Mpox who were confirmed by PCR between July 2022 and April 2023 were included in this study. In total, 405 patients in whom clade 2 was identified were included. Notably, 99% of included patients were men, with 82% of them aged 20-39 years. Furthermore, 71% were men who had sex with men, and 34% were HIV carriers. Regarding the morphology of the lesions, approximately 63% presented with papulonecrotic rash, which sometimes alternated with pustules depending on the stage they were in. All patients presented with systemic symptoms. Five patients required hospital admission, one of whom died, and presented with HIV and severe immunosuppression. Clinical findings suggest that contact during sexual intercourse is the most likely transmission mechanism and genital involvement is the most frequent clinical form. HIV was the primary comorbidity. Genital lesions were common, especially in vulnerable populations such as those who engage in high-risk sexual behaviors.

Indexed as

genital ulcersHIVmonkeypoxMSM

Identifiers

PMID39770778
PMCPMC11678333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.